Bovie Medical Co. (BVX) Downgraded by Zacks Investment Research
According to Zacks, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies. “
Separately, JMP Securities reaffirmed an outperform rating and issued a $5.00 price objective on shares of Bovie Medical in a report on Wednesday, August 3rd.
Shares of Bovie Medical (NYSE:BVX) opened at 5.01 on Tuesday. The company has a 50 day moving average of $4.47 and a 200 day moving average of $2.55. Bovie Medical has a 52 week low of $1.56 and a 52 week high of $5.69. The company’s market cap is $135.53 million.
In other news, insider John J. Mccarthy III bought 90,750 shares of the stock in a transaction on Wednesday, August 17th. The shares were acquired at an average cost of $3.30 per share, for a total transaction of $299,475.00. Following the purchase, the insider now directly owns 115,750 shares of the company’s stock, valued at approximately $381,975. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
An institutional investor recently raised its position in Bovie Medical stock. BlackRock Fund Advisors increased its stake in shares of Bovie Medical Co. (NYSE:BVX) by 27.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 72,051 shares of the medical device company’s stock after buying an additional 15,305 shares during the period. BlackRock Fund Advisors owned 0.27% of Bovie Medical worth $118,000 as of its most recent filing with the SEC.
Bovie Medical Company Profile
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.